Latest News

Sekisui House (TSE:1928) is back in the spotlight after reporting first quarter sales of ¥908,878 million and net income of ¥58,479 million, along with higher earnings per share than a year earlier. See our latest analysis for Sekisui House. Alongside the stronger first quarter, Sekisui House’s share price is now ¥3,289, with a 7 day share price return of 2.69% but a 90 day share price return that is down 7.17%. The 5 year total shareholder return of 84.95% points to solid long term gains and...

Recently, Smc Corporation (SMCAY) formed a hammer chart pattern, a technical signal often interpreted as the price finding support after prior selling pressure. Adding a fundamental angle, Wall Street analysts have raised their earnings estimates for SMC, reinforcing the significance of this emerging technical signal. With these revised earnings expectations in mind, we’ll explore how the hammer pattern might influence SMC’s broader investment narrative for investors. Capitalize on the AI...

Fidia S.p.A.'s ( BIT:FDA ) stock rose after it released a robust earnings report. However, we think that shareholders...

Short seller allegations that T1 Energy (TE) bought solar cells from a banned Chinese supplier despite executive denials have put its compliance with U.S. supply chain rules and access to key tax credits under scrutiny. See our latest analysis for T1 Energy. At a share price of $8.50, T1 Energy has seen a 30 day share price return of 51.52% and a year to date share price return of 8.42%. The 1 year total shareholder return is very large, suggesting strong longer term momentum despite the...

Regeneron Pharmaceuticals (REGN) is back in focus after the World Health Organization recommended its antibody therapy maftivimab for Ebola trials, along with renewed attention on its wider R&D platform and expanding collaborations. See our latest analysis for Regeneron Pharmaceuticals. Despite the recent WHO spotlight on maftivimab and expanded oncology collaborations, the stock has lost momentum. The 30-day share price return is down 14.97% and the year-to-date share price return is down...

If you are trying to figure out whether AST SpaceMobile's current share price lines up with its underlying value, the recent moves in the stock give you plenty to think about. The share price closed at US$82.41, with the stock falling 12.0% over the last 7 days, rising 10.2% over the last 30 days, declining 1.3% year to date and delivering 114.8% over the last year. The 3 year return is very large at more than 10x and the 5 year return is also very large. Recent coverage has focused on AST...

Earlier this month, Norton, part of Gen Digital, launched the external beta of Norton Family Assistant, a 24/7 AI agent that securely connects to tools like Gmail, calendars, messaging apps, and school platforms to help parents manage family logistics across Windows, macOS, iOS, and Android. The product is built on Gen’s Agent Trust Hub, which emphasizes privacy by keeping each family’s data separate and not using it to train AI models, positioning Gen as an early mover in secure,...

REA Group (ASX:REA) is back in focus after multiple broker downgrades and renewed scrutiny of Australia’s proposed tax changes, with investors weighing the risk of softer listing volumes against the company’s recent A$200 million buyback completion. See our latest analysis for REA Group. At A$143.0, the stock has fallen about 16% on a 30 day share price return basis and is down 22.61% year to date. The 1 year total shareholder return of a 37.67% decline contrasts with a 7.41% gain over three...

In early June 2026, Navitas Semiconductor announced the launch of its ultra‑high‑voltage UHV‑TO‑247‑4‑ISO SiC package for 1,200–3,300 V applications, alongside a US$500 million at-the-market equity program and the immediate resignation of director Ranbir Singh, former Chair of the Executive Steering Committee. These moves, combined with Navitas’ visibility in NVIDIA’s AI Factory MGX ecosystem for megawatt-scale AI racks, highlight the company’s ambition to fund and scale its GaN and SiC...

Wondering if Tapestry stock still offers value after its recent run, or if expectations have already been priced in? This article breaks down what the current share price could mean for you. The stock last closed at US$147.42, with returns of 5.2% over 7 days, 11.1% over 30 days, 14.2% year to date and 89.2% over 1 year, plus very large 3-year and 5-year gains of 265.6% and 307.6% respectively. Recent attention on Tapestry has been shaped by ongoing coverage of the luxury sector and its role...

In early June 2026, a federal judge allowed a class-action lawsuit over alleged nitrate contamination in Oregon’s Lower Umatilla Basin to proceed against Lamb Weston and several other defendants, while the company also moved to shut its Broekhuizenvorst, Netherlands, production facility as part of a broader supply chain realignment. This combination of escalating environmental litigation risk and footprint consolidation raises fresh questions about Lamb Weston’s long-term costs, community...

10x Genomics (TXG) stock has drawn fresh attention after recent trading, with returns up about 37% over the past month and about 53% over the past 3 months from a US$28.84 last close. See our latest analysis for 10x Genomics. That recent surge comes after a much tougher stretch, with the share price posting a 73.53% year to date share price return and a very large 176.91% 1 year total shareholder return, but still sitting on a 50.37% 3 year and 85.17% 5 year total shareholder return decline...

In June 2026, Campus AI announced that it had appointed Eiffage as general contractor for a more than €120,000,000 contract to design, build and commission a 400/33 kV, 1.4 GW high-voltage substation and shared infrastructure at its Fouju Campus, mobilising multiple Eiffage divisions and regional subcontractors in Île-de-France. A key feature of the project is a metal-clad substation insulated with low global-warming-potential gas, an environmental innovation that Campus AI and Eiffage...

Recent commentary on PagSeguro Digital (PAGS) is centering on five years of resilient revenue and operating profit growth in Brazil’s tough macro backdrop, coupled with market claims that the stock appears significantly undervalued. See our latest analysis for PagSeguro Digital. At a share price of US$8.96, PagSeguro Digital has seen a 5.04% 7 day share price return and a 3.82% 30 day share price return, although the 90 day share price return is down 4.38% and the year to date share price...

Copa Holdings (NYSE:CPA) released preliminary traffic statistics for May 2026. Passenger traffic and capacity both showed significant year over year growth. Demand outpaced available seats, leading to a higher load factor versus May 2025. The figures highlight operational expansion and robust travel demand for the carrier. Copa Holdings, the Panama-based airline group listed on the NYSE under ticker CPA, is a key player in Latin American air travel. With the latest May 2026 data indicating...

Earlier this week, Alcoa and the Trois Rivières Port Authority inaugurated Alcoa’s modernized Wharf 17 facilities in Quebec, a US$71.8 million upgrade including two fully electric, closed-loop pneumatic ship unloaders to handle alumina and calcined coke for the Deschambault Smelter. This port investment, backed by broader public funding for the Wharfs 16 and 17 modernization, tightens Alcoa’s control over a key logistics hub while aiming to cut environmental impacts and improve supply-chain...

Recent stock performance and business context CRISPR Therapeutics (CRSP) has drawn attention after a recent pullback, with the stock closing at US$49.80 and showing mixed returns over different time frames that may prompt investors to reassess the story. Over the past day the stock declined 0.9%, over the past week it fell 3.9%, and over the past month it declined 5.6%. Looking back over the past 3 months, the share price is up 2.2%, while the year to date move is a decline of 7.4%. For...

Recent commentary on Watsco (WSO) has focused on the stock trading below some estimates of fair value, with investors weighing solid profitability, a debt free balance sheet, and substantial cash against ongoing industry and partner related risks. See our latest analysis for Watsco. Recent share price moves have been mixed, with the stock down about 9% on a 1 month share price return but up 9.5% year to date and supported by a 5 year total shareholder return of 59.4%. This pattern suggests...

CSL has recently cut its FY26 revenue and profit forecasts following earnings downgrades, writedowns and impairments tied to shifts in US immunoglobulin sales channels and softer China albumin prices, ahead of its full-year results and dividend announcement previously scheduled for 18 August 2026. Despite these setbacks, investors appear increasingly focused on CSL’s turnaround prospects and the possibility that future impairments could be more contained than previously feared. We’ll now...

Wondering if Cintas stock is priced fairly or if the market is missing something? This article walks through what the current price might be telling you about value and risk. The stock last closed at US$176.28, with the price falling 2.0% over the past week but rising 7.8% over the past month. The year to date return is down 4.7% and the 1 year return is down 19.8%, compared with gains of 47.4% over 3 years and 108.2% over 5 years. Recent coverage of the commercial services sector has kept...

Why Marex Group (MRX) is back on investor radar Marex Group (NasdaqGS:MRX) has drawn fresh attention after completing an oversubscribed US$500 million perpetual subordinated note issue at a 7.7% coupon, following its Bermuda redomiciliation. This funding move, combined with public backing from institutional investor Night Watch Investment Management, is prompting investors to reassess the stock’s recent performance and valuation. See our latest analysis for Marex Group. At a share price of...

Event context and recent price action Navan (NAVN) has drawn investor attention after a recent pullback, with the stock down 12% over the past day and 6% over the past week, despite gains over the past month and past 3 months. See our latest analysis for Navan. Despite the latest pullback, Navan’s share price return over the past 3 months of 123.93% and year to date share price return of 22.65% suggest momentum has recently been building from a lower base. If this sharp move has you thinking...

Earlier this month, Wesfarmers announced that its Industrial and Safety businesses, Blackwoods and Workwear Group, will be folded into Bunnings Group from 1 July 2026, aligning complementary customer bases while expecting stronger customer value propositions, incremental sales and cost efficiencies with minimal one-off transition costs. The move also coincides with the planned retirement of Industrial and Safety Managing Director Tim Bult and underscores Wesfarmers’ broader 2026 Strategy Day...

argenx (ENXTBR:ARGX) has been in focus after the FDA expanded approval for its flagship drug Vyvgart to cover all adult patients with generalized myasthenia gravis, regardless of antibody status, drawing fresh attention to the stock. See our latest analysis for argenx. argenx’s recent FDA label expansion for Vyvgart and new rheumatology data have arrived alongside a 14.03% 1 month share price return and a 55.91% 1 year total shareholder return, indicating that momentum has been present over...